• Categories
  • Archives

U.S. Lab Says Brazil Cannot Break AIDS Drug Patent

Merck Sharp & Dohme Laboratory believes Brazil does not have enough conditions to request compulsory licensing of antiretroviral medications that integrate the anti-AIDS cocktail. This type of license is equivalent to the break of patents.

“There is no national emergency, the government AIDS program is working very well. Furthermore, the price of Efavirenz – one of the cocktail components – corresponds to 16% of the product’s value in developing countries, because of the cumulative discounts we give the government,” says the laboratory Corporate Communication Director, João Sanches.


According to Sanches, the company has been negotiating, since 2003, the voluntary licensing, which allows the government to produce the medication in Brazil and pay corresponding royalties to the company.


“We expect the government to respect current treats and negotiations,” says Sanches.


Last March 14th, the Ministry of Health requested the voluntary licensing of three medications: Lopinavir/Ritonavir (Abbot), Efavirenz (Merck Sharp & Dohme), and Tenofovir (Gilead Science Incorporation).


The government is now analyzing labs answers. If negotiations do not reach an agreement, the AIDS Interdisciplinary Brazilian Association (Abia) promises to support a possible government decision to break the patents.


AIDS medications are distributed for free for the 154 thousand patients treated by the public health network. The Ministry’s forecast is to treat a total of 180 thousand people this year.


Agência Brasil

Tags:

  • Show Comments (0)

Your email address will not be published. Required fields are marked *

comment *

  • name *

  • email *

  • website *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Ads

You May Also Like

Brazilian Soy Growers Fear They Will Be Ousted from Bolivia

Brazil and Bolivia decided to establish a technical group to evaluate property holdings along ...

Export area of Cumbica Airport in São Paulo, Brazil

For All Its WTO Haggling Brazil Will Get US$ 160 Million… in Loss.

Although official estimates of developing country benefits of the current world trade talks are ...

Brazil Joins Argentina to Build Lab for AIDS Drugs

Argentina and Brazil will join efforts to build a pharmaceutical plant for the production ...

Schooling Is Not Helping Women Narrow Gap With Men in Brazil

The Synthesis of Social Indicators, 2004, released February 23 in Rio de Janeiro by ...

IMF Values Private Investment in Brazil

The Director of the Fiscal Affairs Department of the Monetary International Fund (IMF), Teresa ...

Commitment to Austerity is Sacred, Says Brazil’s New Finance Minister

Latin American stocks advanced, with Brazilian stocks posting the biggest gains on a continued ...

Brazil TAM Spends US$ 7 Billion in 46 New Airbuses

Brazil's flagship airline TAM announced that it has signed firm orders for purchase of ...

At Present Pace Brazil Won’t Eradicate Poverty This Century

The United Nations will hold a general assembly Wednesday, September 14, to assess the ...

In Brazil, Big Farmers Are Small Producers

Brazil has serious economic and social problems that result from the inequality in land ...